A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus
<p>Abstract</p> <p>Background</p> <p>To evaluate the safety of pegaptanib sodium 0.3 mg intravitreal injection in the treatment of neovascular age-related macular degeneration in subjects with or without diabetes mellitus.</p> <p>Methods</p> <p>A...
Main Authors: | Dombi Theresa, Kwok Kenneth K, Sultan Marla B |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Ophthalmology |
Online Access: | http://www.biomedcentral.com/1471-2415/12/37 |
Similar Items
-
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
by: Sobha Sivaprasad
Published: (2008-06-01) -
Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema
by: G. Querques, et al.
Published: (2009-01-01) -
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
by: Sobha Sivaprasad, et al.
Published: (2008-06-01) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
by: Nikolaus Feucht, et al.
Published: (2008-06-01) -
CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB
by: M. Burova, et al.
Published: (2015-12-01)